Teresa Reguly
Teresa Reguly
Partner at Torys LLP
(416) 865-7316
(416) 865-7380
79 Wellington St W, Suite 3000, Box 270, TD Ctr, Toronto, ON
Year called to bar: 2007 (ON)
Teresa’s scientific fluency supports her broad intellectual property skills and business-minded approach, helping clients realize and manage their intellectual property and product regulatory strategy. Teresa provides ongoing advice to clients who sell regulated products in the food, pharmaceutical, biotechnology and medical device industries. She advises on intellectual property and regulatory issues in the chemical, biochemical and pharmaceutical fields, including the validity patentability and infringement of intellectual property rights. Teresa has extensive experience with drafting, filing and prosecuting patent applications and is frequently involved in drafting and negotiating IP licensing, research and development, co-promotion, marketing and confidentiality agreements for her clients. She also provides guidance on Food and Drugs Act compliance, establishment licensing, product licensing, packaging and labeling, drug pricing and formulary listings. She has deep knowledge in the advertising and promotion of consumer products, food and health products, as well as mandatory reporting and corrective actions. Teresa is a registered patent agent in Canada. In September 2009, she was awarded for having achieved the highest overall mark in Canada on the 2008 patent agent exams.
Teresa Reguly is a featured Leading Lawyer in:
Canadian Legal Lexpert Directory
Repeatedly Recommended
Teresa Reguly is also listed in the following publication(s)
Read more about Teresa Reguly in ...
Less Regulation, More Product Pathways?
Critics argue that regulations prevent large food companies from entering the edible cannabis market and that cosmetic and topical products containing cannabis might be best sold in drugstores
On July 17, 2017, Norgine B.V., a European specialist pharmaceutical company, acquired all issued and outstanding shares of Merus Labs International Inc. (Merus), pursuant to a plan of arrangement for $1.65 per common share in cash, including the assumption of all debt obligations, for a total enterprise value of approximately $342 million.
Teresa Reguly in Mondaq ...